You searched for "what is true transparency". Here are the results:
Working Together to Provide Access to Affordable Medicines It’s time to start a community conversation about prescription medicines and the out-of-pocket costs for patients. Several bills under consideration at the Colorado state legislature address prescription drug pricing. The Colorado Bioscience... Read More
CO State Budget & March Forecast Transportation, Education, PERA, and opioid addiction are a few of the areas that will receive funding in the $28.9 billion state budget package passed by the Colorado House of Representatives this week. The budget will now go to the CO State Senate where it will... Read More
UNDER THE DOME The Colorado BioScience Association took formal positions on three bills this week and we continue to evaluate and make recommendations on legislation being introduced. Outlined below are details on the three new bills. Please connect with us if you'd like to weigh in. CBSA SUPPORTS S... Read More
CBSA promotes the interests of more than 725 bioscience companies and their 30,000 employees. We work every day to create an innovation-friendly business environment ensuring that as an industry we deliver value to patients and our state’s economy while creating the next generation of treatments and... Read More
Advocating at the Capitol Today, April Giles, CBSA president & CEO testified in the House Health, Insurance, & Environment committee in opposition to HB18-1358 - Health Care Charges Billing Required Disclosures. The billed died in committee with a vote of 12 – 1. The bill would have required... Read More
UNDER THE DOME The Colorado BioScience Association took formal positions on three bills this week. With 18 working days left of session we continue to evaluate and make recommendations on legislation being introduced. Outlined below are details on four bills on which CBSA recently took a position. P... Read More
Colorado House Votes next week on Prescription Drug Price Transparency Bill (HB18-1260) CBSA continues to advocate against House Bill 1260, Prescription Drug Price Transparency. The bill could stifle bioscience innovation in Colorado and harm patients. Colorado Bioscience Association (CBSA) and BIO... Read More
This week CBSA testified in opposition to House Bill 1009, Diabetes Drug Pricing Transparency Act 2018. The bill was heard in the House Health, Insurance and Environment Committee and passed on a party line vote. It will now move to House Appropriations. We continue to advocate in opposition and tel... Read More
Transparency at the Colorado State Capitol This week CBSA testified in opposition to House Bill 1260, Prescription Drug Price Transparency. The bill was heard in the House Health, Insurance and Environment Committee and passed on a party line vote. It will now move to House Appropriations. We contin... Read More
Urge a NO Vote on HB 1260, Prescription Drug Price Transparency This week CBSA opposed a new bill introduced by the Colorado House that could adversely impact the Colorado bioscience industry, House Bill 1260, Prescription Drug Price Transparency. We need your help to contact your legislator UR... Read More
Networking +
Policy +
Member
Career
Choose